Navigation Links
BioMS Medical to present at UBS Global Life Sciences Conference
Date:9/19/2008

etitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medicals lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA
2. BioMS Medical announces its intention to renew a normal course issuer bid
3. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
4. BioMS Medical Announces Second Quarter 2008 Results
5. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
6. BioMS Medical to present at BMO Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medical to present at Jefferies Healthcare Conference
9. BioMS Medical to present at 2008 BIO International Convention
10. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
11. BioMS Medical announces first quarter 2008 results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... The Prinz Law Office has announced the launch of ... businesses secure legal services in the current economic climate. ... them the opportunity to finance legal services over a ... requiring any equity in their start-up companies. The ... for fixed montly payment arrangements over 6 to 12 ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced ... The Scripps Research Institute ("Scripps") by entering into ... of Dyadic,s patented and proprietary C1 fungus ("C1"). ... successful relationship between the two organizations which began ... annotate the C1 genome for the first time. ...
(Date:12/14/2009)... Dec. 14 Boston Scientific Corporation (NYSE: ... public offering of $2 billion aggregate principal amount of ... The public offering consists of $850 million of ... 6.00 percent notes due January 2020 and $300 million ... Scientific plans to use the net proceeds for general ...
(Date:12/14/2009)... Mass., Dec. 14 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, owing ... atrial fibrillation drug market will increase more than ... billion in 2018 in the United States, France, ... ,, The new Pharmacor report entitled Atrial ...
Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... Alba Therapeutics Corporation,today announced the appointment of Bruce ... a member of its Board of Directors. Mr. ... Advisors, LLC. Previously, he served,as the CEO or ... for several,successful entrepreneurial healthcare companies operating in therapeutic,diagnostic ...
... 3, 2008 A policy comment in Science,today ... sites make explicit claims about the utility of ... by Genelex that,pharmacogenetic testing is "required to effectively ... is:, Paxil (paroxetine) is metabolized through CYP2D6. ...
... Agreement to Produce Reference Standard Reagents to ... ... Strategic,Diagnostics Inc. (Nasdaq: SDIX ) -- a leader in ... announced that it has,been selected by Science Applications International Corporation ...
Other Biology Technology:Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer 2Science Fuels DNA Testing Controversy with Prejudicial Misquote 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 3
(Date:12/15/2009)... 15 December 2009 - Scientists at VIB and Ghent ... for the treatment of septic shock, the major cause ... release of nitric oxide (NO) gas in mice with ... that the animal,s organs showed much less damage, while ... all expectations, since it is generally assumed that nitric ...
(Date:12/15/2009)... release is available in German ., ... everywhere across the globe, cultures vary as to how ... do not use egocentric terms such as ,left, right, ... allocentric notions like ,north, south, east, west, at all ... the bowl" or "There is an snake by your ...
(Date:12/15/2009)... German . , Leipzig: Species distribution models ... distribution of mammals. This is the finding of a ... mammals. The researchers analysed data on species distribution, climate, ... information of the species. Judging by the large differences ... seem to adapt fast to changing climatic conditions. This ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Species distribution models are of only limited value for predicting future mammal distributions 2Pesticides easier detection of pollution and impact in rivers 9791 1Pesticides easier detection of pollution and impact in rivers 9791 2GENova names Dr John Savin as Vice President 56261 1GENova names Dr John Savin as Vice President 56261 2Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index 56259 1Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index 56259 2
... vote is partly genetic, according to a new study ... research, by James H. Fowler and Christopher T. Dawes, ... A. Baker, of the University of Southern California, is ... elections and in a wide range of political activities. ...
... and diving seabirds of the Southern Hemisphere unusually susceptible ... well as commercial fishing, mining, and oil and gas ... many species, according to P. Dee Boersma, of the ... issue of BioScience, Boersma provides a first-person ...
... the growth and development of plants, but what effect ... paper by Nathalie Hoang et al., published in ... examining cryptochromes in flies, mice, and humans. In plants, ... light for functions such as growth, seedling development, and ...
Other Biology News:Political participation is partially rooted in genetic inheritance 2Political participation is partially rooted in genetic inheritance 3A mammalian clock protein responds directly to light 2
...
... Optimization Kits without ammonium sulfate are compatible ... such as Taq and AmpliThem™™ DNA polymerases. ... PCR systems in one experiment by adding ... into the PreMixes supplied with the kit. ...
... FailSafe™ PCR System is the only PCR ... time and every time. It provides accuracy, ... the source or the property of the ... PCR Enzyme Mix, a unique blend of ...
Special grade: for molecular biology Density: 1.000 g/mL (20 C)...
Biology Products: